BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 25996499)

  • 21. Infection prevention and control programme and COVID-19 measures: Effects on hospital-acquired infections in patients with cirrhosis.
    Di Cola S; Gazda J; Lapenna L; Ceccarelli G; Merli M
    JHEP Rep; 2023 May; 5(5):100703. PubMed ID: 36844944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Cheong HS; Kang CI; Lee JA; Moon SY; Joung MK; Chung DR; Koh KC; Lee NY; Song JH; Peck KR
    Clin Infect Dis; 2009 May; 48(9):1230-6. PubMed ID: 19302016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: A randomized trial.
    Merli M; Lucidi C; Di Gregorio V; Lattanzi B; Giannelli V; Giusto M; Farcomeni A; Ceccarelli G; Falcone M; Riggio O; Venditti M
    Hepatology; 2016 May; 63(5):1632-9. PubMed ID: 26529126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
    Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
    Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANALYSIS OF HEALTHCARE ASSOCIATED AND HOSPITAL ACQUIRED INFECTIONS IN CRITICALLY ILL PATIENTS WITH CIRRHOSIS.
    D'Oliveira RAC; Pereira LCD; Codes L; Rocha MS; Bittencourt PL
    Arq Gastroenterol; 2022; 59(1):102-109. PubMed ID: 35442319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis.
    Ariza X; Castellote J; Lora-Tamayo J; Girbau A; Salord S; Rota R; Ariza J; Xiol X
    J Hepatol; 2012 Apr; 56(4):825-32. PubMed ID: 22173153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of infections caused by multidrug-resistant gram-negative bacteria in adult hospitalized patients at Siriraj Hospital.
    Chaisathaphol T; Chayakulkeeree M
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S35-45. PubMed ID: 24772579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infections complicating cirrhosis.
    Piano S; Brocca A; Mareso S; Angeli P
    Liver Int; 2018 Feb; 38 Suppl 1():126-133. PubMed ID: 29427501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
    Lutz P; Nischalke HD; Krämer B; Goeser F; Kaczmarek DJ; Schlabe S; Parcina M; Nattermann J; Hoerauf A; Strassburg CP; Spengler U
    Eur J Clin Invest; 2017 Jan; 47(1):44-52. PubMed ID: 27861767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of bacterial infections in patients with liver cirrhosis. Experience in a Spanish tertiary health center.
    Klímová K; Padilla C; Ávila JC; Clemente G; Ochoa A
    Biomedica; 2016 Mar; 36(1):121-32. PubMed ID: 27622445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany.
    Kremer WM; Gairing SJ; Kaps L; Ismail E; Kalampoka V; Hilscher M; Michel M; Siegel E; Schattenberg JM; Galle PR; Sprinzl MF; Wörns MA; Nagel M; Labenz C
    Ann Hepatol; 2022; 27(5):100719. PubMed ID: 35460883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bacterial infections in hepatic cirrhosis].
    Toledo C; Flores C; Sáenz M; Jiménez P; Tejero A; Ibarra H; León J; Arce M
    Rev Med Chil; 1994 Jul; 122(7):788-94. PubMed ID: 7732229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance.
    Horcajada JP; Shaw E; Padilla B; Pintado V; Calbo E; Benito N; Gamallo R; Gozalo M; Rodríguez-Baño J; ; ;
    Clin Microbiol Infect; 2013 Oct; 19(10):962-8. PubMed ID: 23279375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extremely and pandrug-resistant bacteria extra-deaths: myth or reality?
    Abat C; Fournier PE; Jimeno MT; Rolain JM; Raoult D
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1687-1697. PubMed ID: 29956024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical impact of healthcare-associated acquisition in cirrhotic patients with community-onset spontaneous bacterial peritonitis.
    Kim J; Kang CI; Gwak GY; Chung DR; Peck KR; Song JH
    Korean J Intern Med; 2020 Jan; 35(1):215-221. PubMed ID: 29502362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.
    Allaire M; Cadranel JF; Nguyen TTN; Garioud A; Zougmore H; Heng R; Perignon C; Ollivier-Hourmand I; Dao T
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):264-274. PubMed ID: 31706985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bacterial infections in liver cirrhosis].
    Papp M; Farkas A; Udvardy M; Tornai I
    Orv Hetil; 2007 Mar; 148(9):387-95. PubMed ID: 17344166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.